Trade Gilead ^GILD

Handelsbanken Fonder AB Buys 51,453 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Insider Selling: Gilead Sciences, Inc. (NASDAQ:GILD) CFO Sells 2,500 Shares of Stock

Gilead Sciences (NASDAQ:GILD) Sets New 1-Year High - Should You Buy?

Gilead Sciences, Inc. (GILD): Among Stocks That Analysts Think Will Go Up

Alberta Investment Management Corp Sells 151,193 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Werba Rubin Papier Wealth Management Sells 6,179 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Boston Financial Mangement LLC Decreases Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Atria Wealth Solutions Inc. Sells 2,703 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Stock Holdings Lowered by Atria Wealth Solutions Inc.

No OS Boost With Palbociclib and Endocrine Therapy in Premenopausal Breast Cancer

Is Gilead Sciences (GILD) Outperforming Other Medical Stocks This Year? - February 20, 2025 - Zacks.com

NORTHAMPTON, MA / ACCESS Newswire / February 19, 2025 / Take

The Centrifuge Sessions: How Gilead Sciences Is Impacting Autoimmune Disease

Deutsche Bank Aktiengesellschaft Upgrades Gilead Sciences (NASDAQ:GILD) to "Buy"

Gilead Sciences Inc (GILD) Advances HIV Prevention with FDA Acceptance of Lenacapavir NDA

New York State Common Retirement Fund Lowers Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Callahan Advisors LLC Has $604,000 Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Principal Financial Group Inc. Increases Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Principal Securities Inc. Purchases 4,468 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Blue Trust Inc. Has $326,000 Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Short Interest Update

Gilead Sciences, Inc. (NASDAQ:GILD) Short Interest Down 8.9% in January

Gilead Sciences' (NASDAQ:GILD) Upcoming Dividend Will Be Larger Than Last Year's

Calls of the Day: Gilead Sciences and Merck

Mcdonald Partners LLC Decreases Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Valley Wealth Managers Inc. Cuts Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Kornitzer Capital Management Inc. KS Decreases Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Allworth Financial LP Has $3.35 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Everhart Financial Group Inc. Acquires New Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences patents new PARP-7 inhibitors | BioWorld

Gilead Sciences, Inc. (GILD): A Bull Case Theory

CIBC Asset Management Inc Raises Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

MOKAN Wealth Management Inc. Invests $1.74 Million in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Philip James Wealth Mangement LLC

Gilead Stock Rises 8% Post Q4 Earnings: Should You Buy or Sell? - February 17, 2025 - Zacks.com

Manchester Capital Management LLC Decreases Position in Gilead Sciences, Inc. (NASDAQ:GILD)

CapWealth Advisors LLC Sells 4,276 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Nkcfo LLC Purchases Shares of 29,655 Gilead Sciences, Inc. (NASDAQ:GILD)

Rhumbline Advisers Sells 39,739 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Roman Butler Fullerton & Co. Invests $298,000 in Gilead Sciences, Inc. (NASDAQ:GILD)

AustralianSuper Pty Ltd Purchases 5,989 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Roman Butler Fullerton & Co. Buys Shares of 3,130 Gilead Sciences, Inc. (NASDAQ:GILD)

Banque Pictet & Cie SA Has $4.77 Million Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Best Dividend Stocks To Follow Now - February 12th

Leerink Partnrs Weighs in on Gilead Sciences Q4 Earnings

Chevy Chase Trust Holdings LLC Decreases Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

White Pine Capital LLC Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

DZ Bank Upgrades Gilead Sciences (NASDAQ:GILD) to "Buy"

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Asset Management One Co. Ltd.

Banque Pictet & Cie SA Has $4.77 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Vontobel Holding Ltd. Sells 40,733 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Andrew D. Dickinson Sells 137,676 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) Stock

Maxim Group Reaffirms Their Hold Rating on Gilead Sciences (GILD) | Markets Insider

Leerink Partnrs Predicts Gilead Sciences Q1 Earnings

Avestar Capital LLC Purchases 1,362 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

DZ Bank Upgrades Gilead Sciences (NASDAQ:GILD) to Buy

Gilead Sciences, Inc. (NASDAQ:GILD) Increases Dividend to $0.79 Per Share

Gilead Sciences (NASDAQ:GILD) Price Target Raised to $90.00 at Royal Bank of Canada

Gilead Sciences (NASDAQ:GILD) Price Target Raised to $120.00

Gilead Sciences (NASDAQ:GILD) Reaches New 12-Month High on Strong Earnings

Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, Piper Sandler Analyst Says

Gilead Sciences, Inc. (NASDAQ:GILD) Q4 2024 Earnings Call Transcript

IDEAYA Biosciences Expands Collaboration with Gilead Sciences for Innovative Cancer Treatment

IDEAYA, Gilead To Evaluate Efficacy, Safety Of IDE397+Trodelvy Combination, Stock Up In Pre-Market

The Globe and Mail reports in its Thursday, Feb. 13, edition

Van ECK Associates Corp Sells 219,562 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by TFB Advisors LLC

Evercore ISI Remains a Buy on Gilead Sciences (GILD) | Markets Insider

Clinico-pathological factors predicting pathological response in early triple-negative breast cancer

Biotech Stock Roundup: GILD Up on Q4 Results, BIIB, BMY Down on 2025 Guidance - February 13, 2025 - Zacks.com

S&P 500 ends down on hot US inflation data | The Star

Gilead Sciences (NASDAQ:GILD) Updates FY 2025 Earnings Guidance

Gilead Sciences (NASDAQ:GILD) Releases Quarterly Earnings Results, Beats Expectations By $0.23 EPS

Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says

Gilead Sciences (NASDAQ:GILD) Given New $96.00 Price Target at The Goldman Sachs Group

Gilead Sciences (NASDAQ:GILD) Given New $90.00 Price Target at Royal Bank of Canada

Gilead Sciences (GILD) Stock Surge: Key Reasons Explained

Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, BMO Capital Markets Analyst Says

Certuity LLC Has $775,000 Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences (NASDAQ:GILD) Issues FY 2025 Earnings Guidance

Gilead Earnings: Our $108 Fair Value Reflects Solid Underlying HIV Demand Growth and Margin Strength | Morningstar

Gilead's HIV, Liver Disease, and Oncology Portfolios Support a Wide Moat | Morningstar

Gilead Sciences' (GILD) "Hold" Rating Reiterated at Needham & Company LLC

Gilead Sciences (NASDAQ:GILD) Price Target Raised to $123.00

Gilead price target raised to $123 from $113 at Morgan Stanley | Markets Insider

Soltis Investment Advisors LLC Acquires Shares of 2,616 Gilead Sciences, Inc. (NASDAQ:GILD)

GILD Stock Up on Q4 Earnings and Sales Beat & Upbeat '25 Guidance - February 12, 2025 - Zacks.com

Gilead Sciences (NASDAQ:GILD) Announces Quarterly Earnings Results, Beats Expectations By $0.23 EPS

Gilead Sciences (NASDAQ:GILD) Issues Quarterly Earnings Results

Company Website: https://www.gilead.com/ FOSTER CITY, Cali

Polaris Capital Management LLC Has $38.57 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

MADDEN SECURITIES Corp Decreases Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Visionary Horizons LLC Sells 185 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Why Did Stock Market Drop Today? Walmart’s Forecast Sparks Economic Concerns

Shiba inu news: What is happening to Shiba Inu today?

Dow jones stock markets today: Dow falls 450 points

Lucid stock news today: Is Lucid stock expected to go up?

Forex market update: US Dollar struggles on mixed data

Week Ahead: Australia Inflation and US Core PCE Price Index in Focus

Morning Note: Oil Prices Climb, UK Retail Sales Rise & U.S. PMI

Asian Markets Stagnate on Trade Fears; Alibaba Drives HK Surge